TY - JOUR AU - Huang, C. AU - Wang, Y. AU - Li, X. AU - Ren, L. AU - Zhao, J. AU - Hu, Y. PY - 2020 DA - 2020// TI - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30183-5 DO - 10.1016/S0140-6736(20)30183-5 ID - Huang2020 ER - TY - JOUR AU - Stockman, L. J. AU - Bellamy, R. AU - Garner, P. PY - 2006 DA - 2006// TI - SARS: systematic review of treatment effects JO - PLoS Med VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030343 DO - 10.1371/journal.pmed.0030343 ID - Stockman2006 ER - TY - JOUR AU - Dong, L. AU - Hu, S. AU - Gao, J. PY - 2020 DA - 2020// TI - Discovering drugs to treat coronavirus disease 2019 (COVID-19) JO - Drug Discov Ther VL - 14 UR - https://doi.org/10.5582/ddt.2020.01012 DO - 10.5582/ddt.2020.01012 ID - Dong2020 ER - TY - JOUR AU - Lu, H. PY - 2020 DA - 2020// TI - Drug treatment options for the 2019-new coronavirus (2019-nCoV) JO - Biosci Trends VL - 14 UR - https://doi.org/10.5582/bst.2020.01020 DO - 10.5582/bst.2020.01020 ID - Lu2020 ER - TY - STD TI - WHO. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. UR - https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected ID - ref5 ER - TY - JOUR AU - Sallard, E. AU - Lescure, F. X. AU - Yazdanpanah, Y. AU - Mentre, F. AU - Peiffer-Smadja, N. PY - 2020 DA - 2020// TI - Type 1 interferons as a potential treatment against COVID-19 JO - Antivir Res VL - 178 UR - https://doi.org/10.1016/j.antiviral.2020.104791 DO - 10.1016/j.antiviral.2020.104791 ID - Sallard2020 ER - TY - JOUR AU - Sheahan, T. P. AU - Sims, A. C. AU - Leist, S. R. AU - Schafer, A. AU - Won, J. AU - Brown, A. J. PY - 2020 DA - 2020// TI - Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV JO - Nat Commun VL - 11 UR - https://doi.org/10.1038/s41467-019-13940-6 DO - 10.1038/s41467-019-13940-6 ID - Sheahan2020 ER - TY - JOUR AU - Omrani, A. S. AU - Saad, M. M. AU - Baig, K. AU - Bahloul, A. AU - Abdul-Matin, M. AU - Alaidaroos, A. Y. PY - 2014 DA - 2014// TI - Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study JO - Lancet Infect Dis VL - 14 UR - https://doi.org/10.1016/S1473-3099(14)70920-X DO - 10.1016/S1473-3099(14)70920-X ID - Omrani2014 ER - TY - JOUR AU - Loutfy, M. R. AU - Blatt, L. M. AU - Siminovitch, K. A. AU - Ward, S. AU - Wolff, B. AU - Lho, H. PY - 2003 DA - 2003// TI - Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study JO - JAMA. VL - 290 UR - https://doi.org/10.1001/jama.290.24.3222 DO - 10.1001/jama.290.24.3222 ID - Loutfy2003 ER - TY - JOUR AU - Lai, C. C. AU - Shih, T. P. AU - Ko, W. C. AU - Tang, H. J. AU - Hsueh, P. R. PY - 2020 DA - 2020// TI - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges JO - Int J Antimicrob Agents VL - 55 UR - https://doi.org/10.1016/j.ijantimicag.2020.105924 DO - 10.1016/j.ijantimicag.2020.105924 ID - Lai2020 ER - TY - STD TI - Lokugamage KG, Hage A, Schindewolf C, Rajsbaum R, Menachery VD. SARS-CoV-2 sensitive to type I interferon pretreatment. BioRxiv. 2020. https://doi.org/10.1101/2020.03.07.982264. ID - ref11 ER - TY - STD TI - Zhou Q, Chen V, Shannon CP, Wei X-S, Xiang X, Wang X, et al. Interferon-α2b treatment for COVID-19. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.01061. ID - ref12 ER - TY - STD TI - Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2011400. ID - ref13 ER - TY - JOUR AU - Hung, I. F. -. N. AU - Lung, K. -. C. AU - Tso, E. Y. -. K. AU - Liu, R. AU - Chung, T. W. -. H. AU - Chu, M. -. Y. PY - 2020 DA - 2020// TI - Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial JO - Lancet. VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)31042-4 DO - 10.1016/S0140-6736(20)31042-4 ID - Hung2020 ER - TY - JOUR AU - Morra, M. E. AU - Thanh, L. AU - Kamel, M. G. AU - Ghazy, A. A. AU - Altibi, A. M. A. AU - Dat, L. M. PY - 2018 DA - 2018// TI - Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis JO - Rev Med Virol VL - 28 UR - https://doi.org/10.1002/rmv.1977 DO - 10.1002/rmv.1977 ID - Morra2018 ER -